Breast Neoplasms | Search results | NICE

Showing 1 result for breast neoplasms

Sort by

Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence (TA810)
Evidence-based recommendations on abemaciclib (Verzenios) with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence in adults.
Result type
Technology appraisal guidance
Published
20 July 2022
View recommendations for TA810
Show all sections
Sections for TA810